;PMID: 1059097
;source_file_2855.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..50] = [t:0..50]
;1)sentence:[e:56..127] = [t:56..127]
;2)section:[e:131..154] = [t:131..154]
;3)sentence:[e:158..283] = [t:158..283]
;4)sentence:[e:284..372] = [t:284..372]
;5)sentence:[e:373..523] = [t:373..523]
;6)sentence:[e:524..625] = [t:524..625]
;7)sentence:[e:627..718] = [t:627..718]
;8)sentence:[e:719..908] = [t:719..908]
;9)sentence:[e:909..1116] = [t:909..1116]
;10)sentence:[e:1117..1309] = [t:1117..1309]
;11)section:[e:1313..1357] = [t:1313..1357]

;section 0 Span:0..50
;Proc Natl Acad Sci U S A.  1975 Aug;72(8):3119-23.
(SEC
  (FRAG (NNP:[0..4] Proc) (NNP:[5..9] Natl) (NNP:[10..14] Acad)
        (NNP:[15..18] Sci) (NNP:[19..20] U) (NNP:[21..22] S) (NNP:[23..24] A)
        (.:[24..25] .) (CD:[27..31] 1975) (CC:[32..39] Aug;72-LRB-)
        (CD:[39..40] 8) (-RRB-:[40..41] -RRB-) (CD:[41..46] :3119)
        (::[46..47] -) (CD:[47..49] 23) (.:[49..50] .)))

;sentence 1 Span:56..127
;Gene expression in mouse neuroblastoma cells: properties of the genome.
;[81..94]:malignancy-type:"neuroblastoma"
(SENT
  (NP-HLN
    (NP
      (NP (NN:[56..60] Gene) (NN:[61..71] expression))
      (PP-LOC (IN:[72..74] in)
        (NP (NN:[75..80] mouse) (NN:[81..94] neuroblastoma)
            (NNS:[95..100] cells))))
    (::[100..101] :)
    (NP
      (NP (NNS:[102..112] properties))
      (PP (IN:[113..115] of)
        (NP (DT:[116..119] the) (NN:[120..126] genome))))
    (.:[126..127] .)))

;section 2 Span:131..154
;Zornetzer MS, Stein GS.
(SEC
  (FRAG (NNP:[131..140] Zornetzer) (NNP:[141..143] MS) (,:[143..144] ,)
        (NNP:[145..150] Stein) (NNP:[151..153] GS) (.:[153..154] .)))

;sentence 3 Span:158..283
;Chromatin was prepared from isolated nuclei of proliferating and
;differentiated  cultures of C1300 mouse neuroblastoma cells.
;[263..276]:malignancy-type:"neuroblastoma"
(SENT
  (S
    (NP-SBJ-1 (NN:[158..167] Chromatin))
    (VP (VBD:[168..171] was)
      (VP (VBN:[172..180] prepared)
        (NP-1 (-NONE-:[180..180] *))
        (PP (IN:[181..185] from)
          (NP
            (NP (VBN:[186..194] isolated) (NNS:[195..201] nuclei))
            (PP (IN:[202..204] of)
              (NP
                (NP
                  (NP (VBG:[205..218] proliferating)
                    (NML-2 (-NONE-:[218..218] *P*)))
                  (CC:[219..222] and)
                  (NP (VBN:[223..237] differentiated)
                    (NML-2 (NNS:[239..247] cultures))))
                (PP (IN:[248..250] of)
                  (NP (NN:[251..256] C1300) (NN:[257..262] mouse)
                      (NN:[263..276] neuroblastoma) (NNS:[277..282] cells)))))))))
    (.:[282..283] .)))

;sentence 4 Span:284..372
;Differentiation was induced by  serum withdrawal or treatment with dibutyryl
;cyclic AMP.
(SENT
  (S
    (NP-SBJ-1 (NN:[284..299] Differentiation))
    (VP (VBD:[300..303] was)
      (VP (VBN:[304..311] induced)
        (NP-1 (-NONE-:[311..311] *))
        (PP (IN:[312..314] by)
          (NP-LGS
            (NP (NN:[316..321] serum) (NN:[322..332] withdrawal))
            (CC:[333..335] or)
            (NP
              (NP (NN:[336..345] treatment))
              (PP (IN:[346..350] with)
                (NP (NN:[351..360] dibutyryl) (JJ:[361..367] cyclic)
                    (NN:[368..371] AMP))))))))
    (.:[371..372] .)))

;sentence 5 Span:373..523
;The ability to support  DNA-dependent RNA synthesis when assayed in a
;cell-free system is three times  greater for chromatin from proliferating
;cells.
(SENT
  (S
    (NP-SBJ (DT:[373..376] The) (NN:[377..384] ability)
      (S
        (NP-SBJ (-NONE-:[384..384] *))
        (VP (TO:[385..387] to)
          (VP (VB:[388..395] support)
            (NP
              (ADJP (NN:[397..400] DNA) (HYPH:[400..401] -)
                    (JJ:[401..410] dependent))
              (NN:[411..414] RNA) (NN:[415..424] synthesis))
            (SBAR-ADV
              (WHADVP-1 (WRB:[425..429] when))
              (S
                (NP-SBJ-2 (-NONE-:[429..429] *))
                (VP (VBN:[430..437] assayed)
                  (NP-2 (-NONE-:[437..437] *))
                  (PP (IN:[438..440] in)
                    (NP (DT:[441..442] a)
                      (ADJP (NN:[443..447] cell) (HYPH:[447..448] -)
                            (JJ:[448..452] free))
                      (NN:[453..459] system)))
                  (ADVP-TMP-1 (-NONE-:[459..459] *T*)))))))))
    (VP (VBZ:[460..462] is)
      (ADJP-PRD
        (ADJP
          (NML (CD:[463..468] three) (NNS:[469..474] times))
          (JJR:[476..483] greater))
        (PP (IN:[484..487] for)
          (NP
            (NP (NN:[488..497] chromatin))
            (PP (IN:[498..502] from)
              (NP (VBG:[503..516] proliferating) (NNS:[517..522] cells)))))))
    (.:[522..523] .)))

;sentence 6 Span:524..625
;Histones isolated from  proliferating and differentiated cells were
;fractionated electrophoretically.
;[524..532]:gene-protein:"Histones"
(SENT
  (S
    (NP-SBJ-2
      (NP (NNS:[524..532] Histones))
      (VP (VBN:[533..541] isolated)
        (NP (-NONE-:[541..541] *))
        (PP (IN:[542..546] from)
          (NP
            (NP (VBG:[548..561] proliferating)
              (NML-1 (-NONE-:[561..561] *P*)))
            (CC:[562..565] and)
            (NP (VBN:[566..580] differentiated)
              (NML-1 (NNS:[581..586] cells)))))))
    (VP (VBD:[587..591] were)
      (VP (VBN:[592..604] fractionated)
        (NP-2 (-NONE-:[604..604] *))
        (ADVP-MNR (RB:[605..624] electrophoretically))))
    (.:[624..625] .)))

;sentence 7 Span:627..718
;The relative amounts of proteins present in the five major histone fractions 
;were similar.
;[686..693]:gene-protein:"histone"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[627..630] The) (JJ:[631..639] relative) (NNS:[640..647] amounts))
      (PP (IN:[648..650] of)
        (NP
          (NP (NNS:[651..659] proteins))
          (ADJP (JJ:[660..667] present)
            (PP (IN:[668..670] in)
              (NP (DT:[671..674] the) (CD:[675..679] five) (JJ:[680..685] major)
                  (NN:[686..693] histone) (NNS:[694..703] fractions)))))))
    (VP (VBD:[705..709] were)
      (ADJP-PRD (JJ:[710..717] similar)))
    (.:[717..718] .)))

;sentence 8 Span:719..908
;In contrast, there were significant differences in the nonhistone 
;chromosomal proteins synthesized and associated with the genome of
;proliferating  and differentiating neuroblastoma cells.
;[888..901]:malignancy-type:"neuroblastoma"
(SENT
  (S
    (PP (IN:[719..721] In)
      (NP (NN:[722..730] contrast)))
    (,:[730..731] ,)
    (NP-SBJ (EX:[732..737] there))
    (VP (VBD:[738..742] were)
      (NP-PRD
        (NP (JJ:[743..754] significant) (NNS:[755..766] differences))
        (PP (IN:[767..769] in)
          (NP
            (NP (DT:[770..773] the) (JJ:[774..784] nonhistone)
                (JJ:[786..797] chromosomal) (NNS:[798..806] proteins))
            (VP (VBN:[807..818] synthesized) (CC:[819..822] and)
                (VBN:[823..833] associated)
              (NP (-NONE-:[833..833] *))
              (PP-CLR (IN:[834..838] with)
                (NP
                  (NP (DT:[839..842] the) (NN:[843..849] genome))
                  (PP (IN:[850..852] of)
                    (NP
                      (NP (VBG:[853..866] proliferating)
                        (NML-1 (-NONE-:[866..866] *P*)))
                      (CC:[868..871] and)
                      (NP (VBG:[872..887] differentiating)
                        (NML-1 (NN:[888..901] neuroblastoma)
                               (NNS:[902..907] cells))))))))))))
    (.:[907..908] .)))

;sentence 9 Span:909..1116
;Such differences are reflected by  modifications in the electrophoretic
;banding patterns and in incorporation of  [3H]tryptophan into various
;molecular weight classes of nonhistone chromosomal  polypeptides.
(SENT
  (S
    (NP-SBJ-1 (JJ:[909..913] Such) (NNS:[914..925] differences))
    (VP (VBP:[926..929] are)
      (VP (VBN:[930..939] reflected)
        (NP-1 (-NONE-:[939..939] *))
        (PP (IN:[940..942] by)
          (NP
            (NP (NNS:[944..957] modifications))
            (PP
              (PP (IN:[958..960] in)
                (NP (DT:[961..964] the) (JJ:[965..980] electrophoretic)
                    (NN:[981..988] banding) (NNS:[989..997] patterns)))
              (CC:[998..1001] and)
              (PP (IN:[1002..1004] in)
                (NP
                  (NP (NN:[1005..1018] incorporation))
                  (PP (IN:[1019..1021] of)
                    (NP (NN:[1023..1037] -LSB-3H-RSB-tryptophan)))
                  (PP (IN:[1038..1042] into)
                    (NP
                      (NP (JJ:[1043..1050] various)
                        (NML (JJ:[1051..1060] molecular)
                             (NN:[1061..1067] weight))
                        (NNS:[1068..1075] classes))
                      (PP (IN:[1076..1078] of)
                        (NP (JJ:[1079..1089] nonhistone)
                            (JJ:[1090..1101] chromosomal)
                            (NNS:[1103..1115] polypeptides))))))))))))
    (.:[1115..1116] .)))

;sentence 10 Span:1117..1309
;A functional relationship between changes in the nonhistone  chromosomal
;proteins and variations in the transcriptional activity accompanying 
;differentiation of neuroblastoma cells may exist.
;[1279..1292]:malignancy-type:"neuroblastoma"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1117..1118] A) (JJ:[1119..1129] functional)
          (NN:[1130..1142] relationship))
      (PP (IN:[1143..1150] between)
        (NP
          (NP
            (NP (NNS:[1151..1158] changes))
            (PP (IN:[1159..1161] in)
              (NP (DT:[1162..1165] the) (JJ:[1166..1176] nonhistone)
                  (JJ:[1178..1189] chromosomal) (NNS:[1190..1198] proteins))))
          (CC:[1199..1202] and)
          (NP
            (NP (NNS:[1203..1213] variations))
            (PP (IN:[1214..1216] in)
              (NP
                (NP (DT:[1217..1220] the) (JJ:[1221..1236] transcriptional)
                    (NN:[1237..1245] activity))
                (VP (VBG:[1246..1258] accompanying)
                  (NP
                    (NP (NN:[1260..1275] differentiation))
                    (PP (IN:[1276..1278] of)
                      (NP (NN:[1279..1292] neuroblastoma)
                          (NNS:[1293..1298] cells)))))))))))
    (VP (MD:[1299..1302] may)
      (VP (VB:[1303..1308] exist)))
    (.:[1308..1309] .)))

;section 11 Span:1313..1357
;PMID: 1059097 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1313..1317] PMID) (::[1317..1318] :) (CD:[1319..1326] 1059097)
        (NN:[1327..1328] -LSB-) (NNP:[1328..1334] PubMed) (::[1335..1336] -)
        (NN:[1337..1344] indexed) (IN:[1345..1348] for)
        (NNP:[1349..1357] MEDLINE-RSB-)))
